Rock Ventures Vi, L.p. Third
10% Owner at Rapport Therapeutics, Inc. (RAPP)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $28.3M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| May 11SEC | RAPPRapport Therapeutics, Inc. | Sell Plan | 271,4956,437,733 held (−4%) | $40.12 | $10.9M | -31.3% |
| May 11SEC | RAPPRapport Therapeutics, Inc. | Sell Plan | 5,0186,432,715 held (−0%) | $40.31 | $202K | -31.6% |
| Apr 21SEC | RAPPRapport Therapeutics, Inc. | Sell Plan | 426,0056,709,228 held (−6%) | $40.32 | $17.2M | -31.6% |
- Sell
10% Owner Rock Ventures Vi, L.p. Third sold $10.9M of RAPP at $40.12 — pre-scheduled 10b5-1 plan sale.
- Sell
10% Owner Rock Ventures Vi, L.p. Third sold $202K of RAPP at $40.31 — pre-scheduled 10b5-1 plan sale.
- Sell
10% Owner Rock Ventures Vi, L.p. Third sold $17.2M of RAPP at $40.32 — pre-scheduled 10b5-1 plan sale.